Boxer Capital Management, LLC / DNLI
Boxer Capital Management, LLC’s Denali Therapeutics Inc Position
Does Boxer Capital Management, LLC own Denali Therapeutics Inc (DNLI)? Not currently — the last reported position was 250.0K shares worth $4M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q3 2025
Shares
250.0K
% of Portfolio
+1.16%
Quarters Held
2
position exited
Position History DNLI
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital Management, LLC’s full portfolio or all institutional holders of DNLI.